NovaBridge Biosciences (FRA:0VY)
1.630
+0.020 (1.24%)
At close: Aug 26, 2026
NovaBridge Biosciences Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
30
Market Cap
186.18M EUR
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 632.00K | 2.18M | - |
| Dec 31, 2022 | -1.55M | -15.40M | - |
| Dec 31, 2021 | 13.85M | -222.30M | -94.14% |
| Dec 31, 2020 | 236.15M | 231.84M | 5,381.18% |
| Dec 31, 2019 | 4.31M | -3.51M | -44.90% |
| Dec 31, 2018 | 7.82M | 6.04M | 340.20% |
| Dec 31, 2017 | 1.78M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Biotest GmbH & Co. KGaA | 648.90M |
| Novogenia AG | 54.30M |
| Paion AG | 14.81M |
| MagForce AG | 1.08M |
| Biomark Diagnostics | 37.15K |
| co.don AG | 22.00K |
| bioXXmed AG | 16.73K |
| 2invest AG | -1.64M |
NovaBridge Biosciences News
- 6 days ago - NovaBridge Biosciences Earnings Call Transcript: Q2 2026 - Transcripts
- 6 days ago - NovaBridge Biosciences Earnings release: Q2 2026 - Filings
- 6 days ago - NovaBridge Reports First Half 2026 Financial Results and Highlights Pipeline Momentum and Strategic Execution - GlobeNewsWire
- 8 days ago - NovaBridge Biosciences Slides: Company presentation - Filings
- 13 days ago - NovaBridge to Report First Half 2026 Financial Results and Provide a Corporate Update on Thursday, August 20, 2026 - GlobeNewsWire
- 4 weeks ago - NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026 - GlobeNewsWire
- 2 months ago - NovaBridge CEO Xi-Yong Fu to step down, Srishti Gupta to succeed - TheFly
- 2 months ago - NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer - GlobeNewsWire